BACKGROUND: Management of pharyngitis is commonly based on features which are thought to be associated with Lancefield group A beta-haemolytic streptococci (GABHS) but it is debatable which features best predict GABHS. Non-group A strains share major virulence factors with group A, but it is unclear how commonly they present and whether their presentation differs. AIM: To assess the incidence and clinical variables associated with streptococcal infections. DESIGN AND SETTING: Prospective diagnostic cohort study in UK primary care. METHOD: The presence of pathogenic streptococci from throat swabs was assessed among patients aged ≥5 years presenting with acute sore throat. RESULTS: Pathogenic streptococci were found in 204/597 patients (34%, 95% CI = 31 to 38%): 33% (68/204) were non-group A streptococci, mostly C (n = 29), G (n = 18) and B (n = 17); rarely D (n = 3) and Streptococcus pneumoniae (n = 1). Patients presented with similar features whether the streptococci were group A or non-group A. The features best predicting A, C or G beta-haemolytic streptococci were patient's assessment of severity (odds ratio [OR] for a bad sore throat 3.31, 95% CI = 1.24 to 8.83); doctors' assessment of severity (severely inflamed tonsils OR 2.28, 95% CI = 1.39 to 3.74); absence of a bad cough (OR 2.73, 95% CI = 1.56 to 4.76), absence of a coryza (OR 1.54, 95% CI = 0.99 to 2.41); and moderately bad or worse muscle aches (OR 2.20, 95% CI = 1.41 to 3.42). CONCLUSION: Non-group A strains commonly cause streptococcal sore throats, and present with similar symptomatic clinical features to group A streptococci. The best features to predict streptococcal sore throat presenting in primary care deserve revisiting.
BACKGROUND: Management of pharyngitis is commonly based on features which are thought to be associated with Lancefield group A beta-haemolytic streptococci (GABHS) but it is debatable which features best predict GABHS. Non-group A strains share major virulence factors with group A, but it is unclear how commonly they present and whether their presentation differs. AIM: To assess the incidence and clinical variables associated with streptococcal infections. DESIGN AND SETTING: Prospective diagnostic cohort study in UK primary care. METHOD: The presence of pathogenic streptococci from throat swabs was assessed among patients aged ≥5 years presenting with acute sore throat. RESULTS: Pathogenic streptococci were found in 204/597 patients (34%, 95% CI = 31 to 38%): 33% (68/204) were non-group A streptococci, mostly C (n = 29), G (n = 18) and B (n = 17); rarely D (n = 3) and Streptococcus pneumoniae (n = 1). Patients presented with similar features whether the streptococci were group A or non-group A. The features best predicting A, C or G beta-haemolytic streptococci were patient's assessment of severity (odds ratio [OR] for a bad sore throat 3.31, 95% CI = 1.24 to 8.83); doctors' assessment of severity (severely inflamed tonsils OR 2.28, 95% CI = 1.39 to 3.74); absence of a bad cough (OR 2.73, 95% CI = 1.56 to 4.76), absence of a coryza (OR 1.54, 95% CI = 0.99 to 2.41); and moderately bad or worse muscle aches (OR 2.20, 95% CI = 1.41 to 3.42). CONCLUSION: Non-group A strains commonly cause streptococcal sore throats, and present with similar symptomatic clinical features to group A streptococci. The best features to predict streptococcal sore throat presenting in primary care deserve revisiting.
Authors: R J Cooper; J R Hoffman; J G Bartlett; R E Besser; R Gonzales; J M Hickner; M A Sande Journal: Ann Intern Med Date: 2001-03-20 Impact factor: 25.391
Authors: R J Cooper; J R Hoffman; J G Bartlett; R E Besser; R Gonzales; J M Hickner; M A Sande Journal: Ann Emerg Med Date: 2001-06 Impact factor: 5.721
Authors: J John Melbin Jose; Kootallur N Brahmadathan; Vinod J Abraham; Chiung-Yu Huang; David Morens; Nancy P Hoe; Dean A Follmann; Richard M Krause Journal: Epidemiol Infect Date: 2018-04-04 Impact factor: 2.451
Authors: Shu Ki Tsoi; Pierre R Smeesters; Hannah R C Frost; Paul Licciardi; Andrew C Steer Journal: J Immunol Res Date: 2015-05-25 Impact factor: 4.818
Authors: Paul Little; Beth Stuart; F D Richard Hobbs; Chris C Butler; Alastair D Hay; John Campbell; Brendan Delaney; Sue Broomfield; Paula Barratt; Kerenza Hood; Hazel Everitt; Mark Mullee; Ian Williamson; David Mant; Michael Moore Journal: BMJ Date: 2013-11-25
Authors: Paul Little; Michael Moore; F D R Hobbs; David Mant; Cliodna McNulty; Ian Williamson; Edith Cheng; Beth Stuart; Joanne Kelly; Jane Barnett; Mark Mullee Journal: BMJ Open Date: 2013-10-25 Impact factor: 2.692